Scarica l'app Stockscreener
2.14
2.88%
0.06
Pre-mercato:
2.15
0.010
+0.47%
Precedente Chiudi:
$2.08
Aprire:
$2.08
Volume 24 ore:
520.36K
Relative Volume:
0.46
Capitalizzazione di mercato:
$120.43M
Reddito:
$76.19M
Utile/perdita netta:
$-1.61M
Rapporto P/E:
214.00
EPS:
0.01
Flusso di cassa netto:
$28.98M
1 W Prestazione:
+7.00%
1M Prestazione:
-5.31%
6M Prestazione:
+178.10%
1 anno Prestazione:
+63.36%
Intervallo 1D:
$2.065
$2.195
Intervallo di 1 settimana:
$1.995
$2.195
Portata 52W:
$0.5052
$3.22
Spero Therapeutics Inc Stock (SPRO) Company Profile
Nome
Spero Therapeutics Inc
Settore
Industria
Telefono
857-242-1600
Indirizzo
675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA
Confronta SPRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRO
Spero Therapeutics Inc
|
2.14 | 115.36M | 76.19M | -1.61M | 28.98M | 0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-20 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-09-23 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-10-01 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-01-22 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-16 | Iniziato | Berenberg | Buy |
| 2020-09-29 | Iniziato | Evercore ISI | Outperform |
| 2019-11-05 | Reiterato | H.C. Wainwright | Buy |
| 2019-09-09 | Iniziato | Janney | Buy |
| 2018-02-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-11-27 | Iniziato | BofA/Merrill | Neutral |
| 2017-11-27 | Iniziato | Oppenheimer | Outperform |
| 2017-11-27 | Iniziato | Stifel | Buy |
Mostra tutto
Spero Therapeutics Inc Borsa (SPRO) Ultime notizie
Technical signs of recovery in Spero Therapeutics Inc.Weekly Gains Summary & Daily Chart Pattern Signals - Newser
Is Spero Therapeutics Inc. a candidate for recovery playJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Why Spero Therapeutics Inc. is moving todayQuarterly Portfolio Review & Fast Gaining Stock Reports - Newser
What candlestick patterns are forming on Spero Therapeutics Inc.Quarterly Profit Summary & Verified Momentum Stock Alerts - Newser
Comparing Spero Therapeutics Inc. in custom built stock radarsJuly 2025 Earnings & Low Risk Entry Point Guides - Newser
Trend analysis for Spero Therapeutics Inc. this weekEntry Point & AI Forecasted Entry/Exit Points - Newser
Risk vs reward if holding onto Spero Therapeutics Inc.July 2025 Spike Watch & Growth Focused Stock Reports - Newser
Using data models to predict Spero Therapeutics Inc. stock movementMarket Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Live market analysis of Spero Therapeutics Inc.Weekly Gains Report & Risk Controlled Stock Pick Alerts - Newser
What data driven models say about Spero Therapeutics Inc.’s futureInflation Watch & Verified Short-Term Trading Plans - Newser
Price momentum metrics for Spero Therapeutics Inc. explained2025 Technical Patterns & Long-Term Safe Investment Plans - Newser
Mahadevia Ankit sells Spero Therapeutics (SPRO) stock worth $12946 By Investing.com - Investing.com Canada
Is Spero Therapeutics Inc. subject to activist investor interestWeekly Risk Report & Real-Time Volume Trigger Notifications - khodrobank.com
Spero Therapeutics Inc. stock chart pattern explained2025 Year in Review & Momentum Based Trading Ideas - Newser
Earnings visualization tools for Spero Therapeutics Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - Newser
Multi asset correlation models including Spero Therapeutics Inc.Earnings Risk Report & Low Risk Profit Maximizing Plans - Newser
How sentiment analysis helps forecast Spero Therapeutics Inc.July 2025 Price Swings & Community Trade Idea Sharing Platform - Newser
Published on: 2025-09-03 19:52:17 - beatles.ru
Aug Drivers: Can Spero Therapeutics Inc. lead its sector in growthTrade Performance Summary & Step-by-Step Swing Trade Plans - khodrobank.com
Will Spero Therapeutics Inc. outperform its industry peers2025 Technical Overview & Expert Curated Trade Ideas - khodrobank.com
Analyzing recovery setups for Spero Therapeutics Inc. investorsEarnings Risk Report & Long-Term Investment Growth Plans - Newser
Mahadevia Ankit sells Spero Therapeutics (SPRO) stock worth $12946 - Investing.com
Spero therapeutics (SPRO): COO Keutzer sells $3.3k in stock - Investing.com
What institutional flow reveals about Spero Therapeutics Inc.2025 Trade Ideas & Consistent Growth Equity Picks - Newser
Custom strategy builders for tracking Spero Therapeutics Inc.2025 Support & Resistance & Low Risk High Reward Trade Ideas - Newser
Signal strength of Spero Therapeutics Inc. stock in tech scannersGDP Growth & Daily Entry Point Trade Alerts - Newser
Applying sector rotation models to Spero Therapeutics Inc.2025 Historical Comparison & Reliable Trade Execution Plans - Newser
Ranking Spero Therapeutics Inc. among high performing stocks via tools2025 Growth vs Value & Daily Volume Surge Trade Alerts - Newser
How to integrate Spero Therapeutics Inc. into portfolio analysis tools2025 Analyst Calls & Technical Pattern Alert System - Newser
Published on: 2025-09-02 23:26:02 - Newser
Should you buy the dip on Spero Therapeutics Inc.July 2025 Rallies & Risk Controlled Daily Plans - khodrobank.com
Short interest data insights for Spero Therapeutics Inc.July 2025 Update & Expert Curated Trade Ideas - Newser
Tools to monitor Spero Therapeutics Inc. recovery probabilityMarket Performance Report & Fast Gain Swing Trade Alerts - Newser
Spero Therapeutics Inc Azioni (SPRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Spero Therapeutics Inc Azioni (SPRO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Keutzer Timothy | Chief Operating Officer |
Aug 28 '25 |
Sale |
1.97 |
1,695 |
3,339 |
739,744 |
| Keutzer Timothy | Chief Operating Officer |
Feb 05 '25 |
Sale |
0.78 |
56,537 |
44,099 |
741,439 |
| Rajavelu Esther | CFO & CBO |
Feb 05 '25 |
Sale |
0.78 |
20,689 |
16,137 |
724,720 |
| Shukla Sath | CEO & President |
Feb 05 '25 |
Sale |
0.78 |
155,333 |
121,160 |
1,736,883 |
| Mahadevia Ankit | Director |
Feb 05 '25 |
Sale |
0.78 |
69,219 |
53,991 |
689,866 |
| Rajavelu Esther | CFO & CBO |
Nov 07 '24 |
Sale |
1.31 |
23,351 |
30,590 |
396,515 |
| Rajavelu Esther | CFO & CBO |
Nov 08 '24 |
Sale |
1.30 |
17,245 |
22,418 |
379,270 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):